Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Chugai Commits $220M Into Singapore Drug Lab

  • Post author:Sam
  • Post published:December 28, 2017
  • Post category:BioPharma

The drugmaker intends to expand development of therapeutic antibodies at the lab. Source: BioSpace

Continue ReadingChugai Commits $220M Into Singapore Drug Lab

Kmart to Settle FCA Violation Allegations for $32.2 Million

  • Post author:Sam
  • Post published:December 28, 2017
  • Post category:Drug Industry Daily

Kmart agreed to pay a $32.3 million settlement over charges that its in-store pharmacies failed to report discounted drug prices to federal programs and, therefore, were reimbursed at inflated prices.…

Continue ReadingKmart to Settle FCA Violation Allegations for $32.2 Million

Senators Call on DEA for Guidance on ‘Partial Fill’ of Opioid Prescriptions

  • Post author:Sam
  • Post published:December 28, 2017
  • Post category:Drug Industry Daily

Six U.S. senators called on the Drug Enforcement Administration to update regulations on partial filling of Schedule II drugs to help address the opioid addiction crisis. Source: Drug Industry Daily

Continue ReadingSenators Call on DEA for Guidance on ‘Partial Fill’ of Opioid Prescriptions

FDA to Commit to Faster End-of-Phase Meetings in Guidance to Developers

  • Post author:Sam
  • Post published:December 28, 2017
  • Post category:Drug Industry Daily

FDA released two guidance documents focusing on communications between the agency and drug developers to make drug development more efficient and to help sponsors avoid costly delays. Source: Drug Industry…

Continue ReadingFDA to Commit to Faster End-of-Phase Meetings in Guidance to Developers

2 Small-Cap Biotechs Bestie Celgene is Cutting Back On

  • Post author:Sam
  • Post published:December 27, 2017
  • Post category:BioPharma

Celgene has been unloading some of its shares in two of its investments, CRISPR Therapeutics and Atara Biotherapeutics. Source: BioSpace

Continue Reading2 Small-Cap Biotechs Bestie Celgene is Cutting Back On

FDA Accepts GW Pharma's Epidiolex NDA With Priority Review for Lennox-Gastaut Syndrome and Dravet…

  • Post author:Sam
  • Post published:December 27, 2017
  • Post category:BioPharma

The PDUFA goal date for completion of the FDA review of the Epidiolex NDA is June 27, 2018. Source: BioSpace

Continue ReadingFDA Accepts GW Pharma's Epidiolex NDA With Priority Review for Lennox-Gastaut Syndrome and Dravet…

4 Top-Performing S&P 500 Biotech Stocks of 2017

  • Post author:Sam
  • Post published:December 27, 2017
  • Post category:BioPharma

It was a pretty good year for the stock market, but how about for biotech stocks? Source: BioSpace

Continue Reading4 Top-Performing S&P 500 Biotech Stocks of 2017

Fresenius SE Allegedly Ignored Hundreds of Bad Quality Tests at Plant in India

  • Post author:Sam
  • Post published:December 27, 2017
  • Post category:BioPharma

The agency inspected the plant from May 15 to May 24, 2017, and observed that staffers at the plant were basically gaming the quality control system. Source: BioSpace

Continue ReadingFresenius SE Allegedly Ignored Hundreds of Bad Quality Tests at Plant in India

Shareholders Turn Down Tender Offer to Take BioCanCell Private

  • Post author:Sam
  • Post published:December 27, 2017
  • Post category:BioPharma

Approximately 5.9 million shares were necessary for the tender to be accepted. Source: BioSpace

Continue ReadingShareholders Turn Down Tender Offer to Take BioCanCell Private

China-Focused Life Science Investor Acquires 37% of NovaBay for $28M

  • Post author:Sam
  • Post published:December 27, 2017
  • Post category:BioPharma

After the transaction, it will be NovaBay's largest shareholder with 6.6 million shares, 37% of the total. Source: BioSpace

Continue ReadingChina-Focused Life Science Investor Acquires 37% of NovaBay for $28M
  • Go to the previous page
  • 1
  • …
  • 214
  • 215
  • 216
  • 217
  • 218
  • 219
  • 220
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.